The immune system provides the major host defense against intracellular pathogens and tumors. CD8 T lymphocytes acquire the ability to specifically discriminate infected and malignant cells from normal cells during positive selection in the thymus. CD8 T cells emerge with the ability to specifically and vigorously react with self MHC to which a foreign antigenic peptide is bound, yet remain tolerant to self MHC bound by self peptides. The majority of studies agree that positive selection involves combinatorial recognition by TCR of a peptide/MHC complex yet the nature of the specific peptide/MHC ligand that drives positive selection remains elusive and controversial. The role of peptide in positive selection of the T cell repertoire is at the heart of several unresolved issues. If peptide is involved during development, how does it impact on the peptide specificity of peripheral CD8 T cell activation? Furthermore, the nature of the peptides involved and their relationship to the antigenic peptides remains a matter of controversy. In addition, the extent to which a single peptide/MHC can drive positive selection is still highly controversial. For example, an issue that remains hotly debated is whether specific interaction with any one self peptide selects a limited or diverse set of TCRs. Although several elegant previous reports have addressed these questions, in particular using the OVAp/Kb and VSVp/Kb systems, it has been difficult to extend in vitro findings using organ culture to in vivo models because of the enormity of the pool of self peptides. Thus, defining the relationship between the peptide/MHC complexes that drive positive selection and the selected repertoire remains a challenge. However we have recently developed unique mouse strains that express only the OVAp/Kb complex or the VSVp/Kb complex. Using rigorous clonal T cell approaches coupled with isolation of Kb self peptides and extensive tests of peptide specificity, experiments proposed in this application will define the role of peptide in CD8 T cell selection. These studies will address unresolved questions regarding CD8 T cell development. We will determine how selection on a single peptide/MHCI complex influences the size and diversity of the CD8 T cell repertoire. This analysis will allow us to determine if positive selection is indeed peptide specific. We will establish the relationship between the selecting and cognate peptides and we will determine the impact of structural similarity on the development and function of the CD8 T cell repertoire.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI027568-16
Application #
7428856
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Kehn, Patricia J
Project Start
1989-09-30
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
16
Fiscal Year
2008
Total Cost
$361,970
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Hoerter, John A H; Brzostek, Joanna; Artyomov, Maxim N et al. (2013) Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC. J Exp Med 210:1807-21
Wang, Baomei; Primeau, Tina M; Myers, Nancy et al. (2009) A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire. Science 326:871-4
Truscott, Steven M; Wang, Xiaoli; Lybarger, Lonnie et al. (2008) Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides. J Biol Chem 283:7480-90
Mitaksov, Vesselin; Truscott, Steven M; Lybarger, Lonnie et al. (2007) Structural engineering of pMHC reagents for T cell vaccines and diagnostics. Chem Biol 14:909-22
Truscott, Steven M; Lybarger, Lonnie; Martinko, John M et al. (2007) Disulfide bond engineering to trap peptides in the MHC class I binding groove. J Immunol 178:6280-9
Primeau, Tina; Myers, Nancy B; Yu, Y Y Lawrence et al. (2005) Applications of major histocompatibility complex class I molecules expressed as single chains. Immunol Res 32:109-21
Lybarger, Lonnie; Yu, Y Y Lawrence; Miley, Michael J et al. (2003) Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J Biol Chem 278:27105-11
Hornell, Tara M C; Myers, Nancy; Hansen, Ted H et al. (2003) Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity. J Immunol 170:4506-14
Yu, Yik Y L; Netuschil, Nikolai; Lybarger, Lonnie et al. (2002) Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol 168:3145-9
Hornell, T M; Martin, S M; Myers, N B et al. (2001) Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells. J Immunol 167:4207-14

Showing the most recent 10 out of 23 publications